Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

QAAGZX vs. SCHLX: which is better?

Bottom line

QAAGZX vs SCHLX: the short answer

QAAGZX (T. Rowe Price Health Sciences Portfolio) and SCHLX (DWS Health and Wellness Fund) are both etfs.

But QAAGZX is far broader, holding 277 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.

QAAGZX is cheaper at 0.86% vs 1.06% — a difference of $20 a year per $10,000 invested.

Updated Nov 19, 2026

QAAGZX vs SCHLX side by side

QAAGZXSCHLX
TypeETFMutual fund
Fund familyT. Rowe PriceDWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.86%1.06%
Annual cost per $10k$86$106
10-yr cost on $10k (prospectus)$1,061$1,294
Max front loadNone0%
12b-1 fee0%0%
1-yr return+18.1%—
5-yr return (annualized)+4.1%—
10-yr return (annualized)+9.0%—
Best quarter+23.4%—
Worst quarter−15.8%—
Net assets (fund)$751.7M$231.8M
Number of holdings27765
Portfolio turnover65%2%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

15 of QAAGZX's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingQAAGZXSCHLX
Eli Lilly & Co14.06%13.85%
Johnson & Johnson6.64%6.19%
Unitedhealth Group Inc5.88%5.73%
Abbvie Inc5.12%4.90%
Merck & Co. Inc.4.00%4.85%
Gilead Sciences Inc2.79%2.78%
Thermo Fisher Scientific Inc2.53%3.46%
Vertex Pharmaceuticals Inc2.26%2.45%
Bristol-myers Squibb Co2.12%1.50%
Abbott Laboratories1.91%2.39%
Intuitive Surgical Inc1.89%2.69%
Amgen Inc1.80%2.88%
Stryker Corp1.78%2.61%
Danaher Corp1.44%2.13%
Cardinal Health Inc1.04%1.34%

Source: SEC Form N-PORT

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between QAAGZX and SCHLX?
QAAGZX (T. Rowe Price Health Sciences Portfolio) and SCHLX (DWS Health and Wellness Fund) are both etfs. But QAAGZX is far broader, holding 277 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
Which is cheaper, QAAGZX or SCHLX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both QAAGZX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.